What is HPV ?
HPV is a very common virus, transmitted through skin-to-skin or sexual contact.
The HPV test is done from a sample of cervical cells.
More than 99%1 of cervical cancer is caused by HPV. Every year, 500 0001 women are diagnosed with cervical cancer worldwide.
Over 100 types of HPV have been identified, however, only some types are known to cause health problems such as genital warts and cancers.
HPV 16 and 18 are the highest risk types known to cause about 70% of all cervical cancers. The Roche platform (approved by Health Canada2 ) is utilized by Procrea Fertilty and can determine the important high risk types HPV 16 AND 18.
- In the majority of women, HPV does not cause problems. They are able to fight off the infection before it causes any problems. For some, however, the infection persists.
- Men also can get HPV. However, it is rare for HPV to cause serious problems in men.
Getting the right tests can protect and/or prevent cervical cancer
There are two tests that can protect you from cervical cancer: a Pap test (see more information on Pap tests under Cytology/ThinPrep® in the Other Services section) and an HPV test. For both tests, a doctor or nurse collects a sample of your cervical cells during your gynecologic exam.
The HPV Test/Chlamydia trachomatis (CT) AND/OR Neisseria gonorrhoeae (NG)
- The HPV test uses advanced, molecular technology to detect high-risk types of HPV:
16,18,31,33,35,39,45,51,52,56,58,59 which can cause cervical cancer and other high risk types which may cause cancer 66 and 68.
- It is important to know if you are infected by the virus to know your risk of developing cervical cancer and to determine your need for additional exams – or not.
*From the same specimen an analysis can be performed to detect a Chlam/Gono infection
Learn more about HPV at http://www.hpvinfo.ca/
Cobas® 4800 is a registered trademark of Roche. ThinPrep® is a registered trademark of Hologic Corporation
2Institut national de santé publique : GUIDE DE PRATIQUE POUR LES ANALYSES DE LABORATOIRE EN LIEN AVEC LES ITSS, Titre: DÉTECTION DU VIRUS DU PAPILLOME HUMAIN À HAUT RISQUE AOÛT 2013